GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

Omada Health OMDA · USD

Health Care · US listing · 🇺🇸 United States

Compare

15.09

0.00%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Omada Health

From its filings with the US Securities and Exchange Commission

SEC filings

Omada Health is based in South San Francisco, California and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker OMDA. The SEC classifies its business as health services. In the fiscal year to 31 December 2025, it reported revenue of $260.2m and a net loss of $12.8m. At that date it held total assets of $305.4m and shareholders' equity of $229.7m.

In its own words

Our mission is to bend the curve. Our hope is that, one day, tomorrow’s epidemiologists will notice a bend in disease curves, wonder what might be happening, and conclude that part of that impact has been Omada. As part of that mission, we strive to inspire and enable people to make lasting health changes on their own terms. We deliver virtual care between doctor’s visits, providing an engaging, personalized, and integrated experience for the individuals in our programs, which we call our “members.” Our care is designed to improve their health while delivering value for the employers, health insurance companies (“health plans”), health systems, pharmacy benefit managers (“PBMs”), and other entities that cover the cost of our programs. Our platform is grounded in evidence and supported by peer-reviewed clinical research and third-party accreditations, which we believe enhances credibility with customers, our reseller partners, and other stakeholders. We differentiate through our human-led, technology-enabled care model, which combines proactive Care Teams with data-driven tools to deliver personalized support at scale. We call this approach Compassionate Intelligence. We work to develop trust with each member and use technology to help us personalize their experience, enabling us to unlock results at scale.

Quoted from its 10-K, filed 6 Mar 2026. Read the filing on SEC.gov ↗

Company facts

Sector
Health Care
Industry
Health Care Providers & Services
Listed since
6 Jun 2025
Employees
916
Head office
611 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA, 94080
Incorporated in
DE
Classification
Services-Health Services
Filer status
Non-accelerated filer<br>Emerging growth company

Leadership

Pay as last reported

  • Ms. Jeryl HillemanLead Independent Chairman of the Board$218,039
  • Mr. Wei-Li ShaoPresident$1.2m
  • Mr. Sean DuffyChief Executive Officer, Co-Founder, Director, since 2011$1.2m
  • Mr. Steve CookChief Financial Officer$838,316
  • Dr. Anne BealIndependent Director$473,107
  • Mr. Trevor FetterIndependent Director$93,817
  • Dr. Sachin JainIndependent Director$490,978
  • Ms. Julie KlapsteinIndependent Director$476,168
  • Dr. Jonathan RootIndependent Director
  • Mr. Adam StaviskyIndependent Director$481,606

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Headquartered in San Francisco, California with 916 employees.
  • Offers multiple digital health programs including Omada for Prevention & Weight Health, Diabetes, Hypertension, and MSK.
  • IPO scheduled for 2025-06-06 with a single operating segment focused on virtual care programs.

Weaknesses

  • Source description mentions 859 employees, conflicting with the provided 916 employee count.
  • IPO date is in the future (2025-06-06), indicating the company is not yet publicly traded.
  • Source description states the company has one operating segment, but the provided data does not confirm this.

Opportunities

  • Digital health services market growth in the health care sector.
  • Expansion of virtual care program offerings to address chronic conditions like diabetes and hypertension.
  • Potential for increased market share in digital health solutions post-IPO.

Threats

  • Future IPO date may delay market entry and capital access.
  • Conflicting employee count in source description may indicate data reliability issues.
  • Competition in the digital health services market could impact growth.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.